register

ESG

Pioneering partnership elevates rural health beyond an afterthought

Health Industry Hub | November 26, 2025 |

Almost 30% of Australia’s population live in rural and remote areas. This Rural Health Month, attention turns to the clinicians and allied health professionals who form the backbone of healthcare in these communities.

In this Health Industry Hub podcast, Fran Avon, CEO of the Rural Doctors Foundation, and Kate Roberts, Sustainability Lead at Roche, discuss how strategic partnerships are strengthening frontline teams in environments where resources are often limited.

For the Rural Doctors Foundation, awareness is just the beginning; programs such as GPs4RuralDocs deliver targeted care to health professionals, enhancing their capacity in complex, rural settings. Together, Avon and Roberts unpack how this partnership enables healthcare teams to navigate both professional pressures and self-care, ultimately improving patient outcomes and maintaining the critical healthcare workforce in rural communities.

Roberts further explores how this initiative weaves into Roche’s wider ESG strategy, demonstrating how investment in rural health aligns with corporate commitments to social responsibility and sustainable impact. Avon also reflects on the upcoming federal budget, exploring the funding and policy priorities needed to ensure rural communities have equitable access to healthcare.

This episode offers a compelling look at the critical role of collaboration in shaping the future of health equity.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.